Janney Montgomery Scott
VKTX icon

Janney Montgomery Scott’s Viking Therapeutics VKTX Stock Holding History

Janney Montgomery Scott’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$999K Buy
+25,599
New +$827K ﹤0.01% 1926
2026
Q1 		– Sell
-17,267
Closed -$607K – 3070
2025
Q4 		$607K Buy
17,267
+7,891
+84% +$280K ﹤0.01% 2067
2025
Q3 		$246K Sell
9,376
-36,568
-80% -$1.09M ﹤0.01% 2611
2025
Q2 		$1.22M Buy
45,944
+6,415
+16% +$169K ﹤0.01% 1465
2025
Q1 		$955K Sell
39,529
-3,083
-7% -$97.4K ﹤0.01% 1572
2024
Q4 		$1.72M Buy
42,612
+21,627
+103% +$1.23M ﹤0.01% 1235
2024
Q3 		$1.33M Sell
20,985
-3,611
-15% -$212K ﹤0.01% 1351
2024
Q2 		$1.3M Sell
24,596
-4,490
-15% -$294K ﹤0.01% 1307
2024
Q1 		$2.38M Buy
+29,086
New +$1.29M 0.01% 1075
2018
Q3 		– Sell
-12,000
Closed -$114K – 2137
2018
Q2 		$114K Buy
+12,000
New +$79.8K ﹤0.01% 1935

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janney Montgomery Scott's VKTX Position: Q2 2026 in Review

Janney Montgomery Scott opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 25,599 shares worth $999K. The stake represents ﹤0.01% of the portfolio and ranks #1926 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in VKTX as recently as Q4 2025.

Janney Montgomery Scott first reported a position in VKTX in Q2 2018 and has held it in 10 quarters since. The position peaked at $2.38M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Janney Montgomery Scott held 25,599 shares of Viking Therapeutics worth $999K as of Q2 2026.
  • Viking Therapeutics was a new Janney Montgomery Scott position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1926 holding.
  • Janney Montgomery Scott first reported a position in Viking Therapeutics in Q2 2018 and has held it in 10 quarters since.
  • Janney Montgomery Scott's Viking Therapeutics position peaked at $2.38M in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.